Navigation Links
MichBio Announces Annual Meeting Keynote and Pre-Meeting Workshop
Date:2/19/2008

ANN ARBOR, Mich., Feb. 19 /PRNewswire/ -- MichBio, the association for Michigan life science, will host Joseph C. Papa, chairman and chief executive officer of Allegan, MI-based Perrigo Company, as the keynote speaker for its April 22 Annual Meeting in Ann Arbor. Papa's topic will be "Meeting the World's Growing Need for Quality, Affordable Healthcare Products."

Papa joined Perrigo in October 2006 as president and chief executive officer. He was elected to the company's Board of Directors in November 2006 and appointed chairman of the board in October 2007. He previously served as chairman and chief executive officer of the Pharmaceutical and Technologies Services segment of Cardinal Health. Prior to that position he served as president and chief operating officer of Watson Pharmaceuticals. Additionally, he has held management positions at DuPont Pharmaceuticals, Pharmacia Corporation, G.D.Searle and Novartis.

Perrigo is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. Its primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom.

The MichBio Annual Meeting draws approximately 200 of the industry's leaders and most influential biotech professionals from across the state. It will be held at the Kensington Court Hotel in Ann Arbor, MI. Reception and networking begin at 5:30 p.m. followed by dinner meeting and presentation at 6:30 p.m. The cost before April 20 is $80 for members, $110 for non-members. After April 20 the cost increases to $100 and $130, respectively. For sponsorship information and to register, please visit http://www.michbio.org.

Capital Formation Workshop Will Lead into Annual Meeting

Immediately preceding its Annual Meeting, MichBio will present a workshop titled, "Capital Formation: Lost in Translation." The workshop will explain the benefits and clarify the processes and lingo involved in raising money from non-dilutive funding like SBIR and STTR programs, debt sources such as angel investors and the Michigan Economic Development Corp., and equity sources such as venture capital and corporate investment. There will be ample time for questions and answers. The program is ideally suited for those involved or interested in starting or growing life sciences businesses.

The workshop will run from 2-5:30 p.m. at the Kensington Court on April 22 prior to the Annual Meeting reception. The cost is $75 for MichBio members and $100 for non-members. The combined price for the workshop and Annual Meeting is $130 for members and $185 for non-members. Registration is at http://www.michbio.org.

MichBio is committed to driving the growth of Michigan's life science industry and to fostering the collective impact of its members by serving as their unified voice and by providing them with education, information, connections and other services. MichBio members include life sciences companies, academic and research institutions, bioscience service providers, and related organizations.


'/>"/>
SOURCE MichBio
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. MichBio Responds to Governors Plan to Repeal Tort Reform Laws
2. MichBio Expo Opens in Lansing Next Week
3. MichBio Announces Student Career Day at Michigan State University
4. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
5. MichBio Announces Expo Tours; Extends Deadline for Innovator Showcase Applications
6. Michigan Life Sciences Pipeline to Kick Off MichBio Expo
7. Cadient Group Announces Recent Executive Promotions
8. Pharmion Corporation Announces 2007 Operating Results
9. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
10. Advanced Life Sciences Announces Fourth Quarter and Full Year 2007 Financial Results
11. Edwards Lifesciences Announces Organizational Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):